Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764257 · ClinicalTrials.gov registry record · Phase 3
PREVELLE Shape (CX002) Dermal Filler Protocol
A Phase 3 study of Correction of Nasolabial Folds and Lip Augmentation, sponsored by Mentor Worldwide.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00764257 is a Phase 3 study of Correction of Nasolabial Folds and Lip Augmentation that has completed, run by Mentor Worldwide. The trial reports 1 study location across 1 state.
The verdict
NCT00764257, a Phase 3 study of Correction of Nasolabial Folds and Lip Augmentation, has completed, sponsored by Mentor Worldwide.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
The purpose of this study was to assess PREVELLE Shape (CX002), with respect to safety and efficacy for one year following treatment, for correction of facial nasolabial folds and when applied as an intradermal implant for lip augmentation.
Conditions Studied
Interventions
- DEVICE PREVELLE Shape
- DEVICE Restylane
Study Locations (1)
California
- Mentor Worldwide, LLC - Santa Barbara
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-10 |
| Est. Completion | 2007-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00764257
The ClinicalTrials.gov registry entry for NCT00764257 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Mentor Worldwide, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Correction of Nasolabial Folds and Lip Augmentation appearing as the primary indexed condition, and to 2 interventions - of which PREVELLE Shape is the first listed.
NCT00764257 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00764257 about?
NCT00764257 is a clinical study titled "PREVELLE Shape (CX002) Dermal Filler Protocol". The purpose of this study was to assess PREVELLE Shape (CX002), with respect to safety and efficacy for one year following treatment, for correction of facial nasolabial folds and when applied as an intradermal implant for lip augmentation.
What is the current status of trial NCT00764257?
This trial is currently completed. It is a Phase 3 study. The study started on 2004-10. Estimated completion is 2007-01.
What conditions does trial NCT00764257 study?
This clinical trial studies the following conditions: Correction of Nasolabial Folds and Lip Augmentation.
What interventions are being tested in trial NCT00764257?
The interventions under investigation include: PREVELLE Shape (DEVICE), Restylane (DEVICE).
Who is sponsoring clinical trial NCT00764257?
This trial is sponsored by Mentor Worldwide, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00764257 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.